X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-03-11 | CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S - Sale | $0.67 | -21,029 | 260,165 | -7% | -$14,085 | ||||||
2024-03-11 | CDTX | Sandison Taylor | Chief Medical Officer | S - Sale | $0.67 | -20,662 | 347,095 | -6% | -$13,839 | ||||||
2024-03-11 | CDTX | Ward Shane | COO, CLO | S - Sale | $0.67 | -20,473 | 198,770 | -9% | -$13,713 | ||||||
2024-03-11 | CDTX | Shah Preetam | CFO, CBO | S - Sale | $0.67 | -18,931 | 227,210 | -8% | -$12,680 | ||||||
2023-09-11 | CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S - Sale | $0.95 | -18,469 | 277,194 | -6% | -$17,509 | ||||||
2023-09-11 | CDTX | Sandison Taylor | Chief Medical Officer | S - Sale | $0.95 | -18,793 | 363,757 | -5% | -$17,810 | ||||||
2023-08-14 | CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | P - Purchase | $0.97 | +10,000 | 295,663 | +4% | +$9,700 | ||||||
2023-08-08 | CDTX | Stein Jeffrey | Pres, CEO | P - Purchase | $0.96 | +50,000 | 1,579,996 | +3% | +$47,885 | ||||||
2023-03-27 | CDTX | Stein Jeffrey | Pres, CEO | P - Purchase | $1.04 | +50,000 | 1,246,246 | +4% | +$51,855 | ||||||
2023-03-13 | CDTX | Ward Shane | COO, CLO | S - Sale | $1.53 | -4,329 | 84,576 | -5% | -$6,623 | ||||||
2023-03-13 | CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S - Sale | $1.53 | -7,562 | 191,663 | -4% | -$11,570 | ||||||
2023-03-13 | CDTX | Shah Preetam | CFO, CBO | S - Sale | $1.53 | -6,648 | 148,141 | -4% | -$10,171 | ||||||
2023-03-13 | CDTX | Sandison Taylor | Chief Medical Officer | S - Sale | $1.53 | -7,203 | 288,550 | -2% | -$11,021 | ||||||
2023-01-12 | CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S - Sale | $1.20 | -11,814 | 199,225 | -6% | -$14,177 | ||||||
| D | 2022-09-19 | CDTX | Shah Preetam | CFO, CBO | S - Sale+OE | $0.77 | -15,642 | 150,789 | -9% | -$12,035 | |||||
2022-09-12 | CDTX | Sandison Taylor | Chief Medical Officer | S - Sale | $0.68 | -18,478 | 291,753 | -6% | -$12,656 | ||||||
2022-09-12 | CDTX | Tari Leslie | CHIEF SCIENTIFIC OFFICER | S - Sale | $0.68 | -18,159 | 207,039 | -8% | -$12,437 | ||||||
2022-09-12 | CDTX | Daruwala Paul | COO | S - Sale | $0.68 | -16,199 | 221,099 | -7% | -$11,095 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |